Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.50 |
| ▸ | TPMT | P51580 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SELL | P14151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7080111 | 0.95 | KDM4E (0.61) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL15198821 | 0.87 | ALDH1A1 (0.53) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL10932391 | 0.87 | CA12 (0.60) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL12852899 | 0.87 | TPMT (0.64) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL19005488 | 0.86 | KDM4E (0.49) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| Hydrochloric Acid SCHEMBL10935483 | 0.85 | CA12 (0.58) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL12260647 | 0.85 | KDM4E (0.52) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL14107722 | 0.85 | TPMT (0.61) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL12878515 | 0.85 | KDM4E (0.52) | KDM4EALDH1A1MEN1KMT2ATPMT | |
| SCHEMBL24914714 | 0.84 | MAPT (0.50) | KDM4EALDH1A1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0654659-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1997-02-12 | — | — | EP | claimed |
| EP-0345781-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1995-08-30 | — | — | EP | claimed |
| EP-0654659-A1 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1995-05-24 | — | — | EP | claimed |
| US-4994238-A | Constant volume chemical analysis test device | ROCHE DIABETES CARE, INC. | 1991-02-19 | — | — | US | claimed |
| EP-0345781-A2 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-12-13 | — | — | EP | claimed |
| US-11207645-B2 | Composite semipermeable membrane and spiral wound separation membrane element | NITTO DENKO CORPORATION (JP) | 2021-12-28 | — | — | US | disclosed |
| US-20200061548-A1 | COMPOSITE SEMIPERMEABLE MEMBRANE AND SPIRAL WOUND SEPARATION MEMBRANE ELEMENT | NITTO DENKO CORPORATION (JP) | 2020-02-27 | — | — | US | disclosed |
| US-9772568-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-09-26 | — | — | US | disclosed |
| US-20170174537-A1 | SELECTIVELY PERMEABLE GRAPHENE OXIDE MEMBRANE | NITTO DENKO CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
| US-20160291489-A1 | ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2016-10-06 | — | — | US | disclosed |
| EP-2988596-A2 | COMPOUNDS PROMOTING PLANT GROWTH | Albert-Ludwigs-Universität Freiburg (DE) | 2016-03-02 | — | — | EP | disclosed |
| US-20150344624-A1 | CROSS-LINKING POLYMER, POLYMER RESIN COMPOSITION, AND POLYMER FILM | KOLON INDUSTRIES, INC. (KR) | 2015-12-03 | — | — | US | disclosed |
| EP-1789794-A1 | MULTI-CHROMOPHORIC QUENCHER CONSTRUCTS FOR USE IN HIGH SENSITIVITY ENERGY TRANSFER PROBES | Applera Corporation, Applied Biosystems Group (US) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006031851-A1 | MULTI-CHROMOPHORIC QUENCHER CONSTRUCTS FOR USE IN HIGH SENSITIVITY ENERGY TRANSFER PROBES | APPLERA CORPORATION (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20060063186-A1 | Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes | APPLERA CORPORATION (US) | 2006-03-23 | — | — | US | disclosed |
| EP-0654659-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1997-02-12 | — | — | EP | disclosed |
| EP-0345781-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1995-08-30 | — | — | EP | disclosed |
| EP-0654659-A1 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1995-05-24 | — | — | EP | disclosed |
| US-4994238-A | Constant volume chemical analysis test device | ROCHE DIABETES CARE, INC. | 1991-02-19 | — | — | US | disclosed |
| EP-0345781-A2 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063186-A1 | Multi-chromophoric quencher constructs for use in high sensitivity energy transfer probes | ABCG2, SLC46A1, QTRT1 | KDM4E 1153/4885ALDH1A1 4046/4885MEN1 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.